Dalakas, Marinos C.Dalmau Obrador, Josep2024-03-252024-03-252023-06-202332-7812https://hdl.handle.net/2445/209126With the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA)vaccinations, we have been witnessing a new era in vaccinology because these vaccines do not contain viral proteins but mRNA or viral vectors that instruct the cells to make viralspecific protective antibodies. To effectively fight SARS-CoV-2 infection, however, these vaccines need to induce both humoral and cell-mediated immune responses, with antibodies that block viral replication and viral-specific T cells that kill viral-infected cells and generate antibodyproducing plasma cells and long-lived memory cells.3 p.application/pdfengcc by-nc-nd (c) Dalakas, Marinos C. et al, 2022http://creativecommons.org/licenses/by-nc-nd/3.0/es/COVID-19VacunesCOVID-19Vaccinesinfo:eu-repo/semantics/article2023-06-20info:eu-repo/semantics/openAccess933060535728948